2-[2-[4-[2-[2-[1,3-Dihydro-1,1-bis(4-hydroxyphenyl)-3-oxo-5-isobenzofuranthioureidyl]ethylaminocarbonyl]ethyl]phenyl] ethylamino]-5′-N-ethylcarboxamidoadenosine (FITC-APEC): A fluorescent ligand for A2a-adenosine receptors

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Fluorescence

• Publication date

  1992-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00865279PMID 23772170PMCID PMC3682427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice

  2004cited by this paper
• Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

  1992cited by this paper
• AHN 683: a fluorescent ligand for peripheral-type benzodiazepine receptors.

  1992cited by this paper
• Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

  1992cited by this paper
• A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.

  1992cited by this paper
• ADENOSINE AND THE CENTRAL NERVOUS SYSTEM CONTROL OF AUTONOMIC FUNCTION

  1991cited by this paper
• Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.

  1991cited by this paper
• Nonisotopic receptor-binding assay for benzodiazepine receptors utilizing a fluorophore labeled ligand.

  1991cited by this paper
• Multiple fluorescent ligands for dopamine receptors. II. Visualization in neural tissues.

  1991cited by this paper
• Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity.

  1991cited by this paper
• Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice.

  1991cited by this paper
• Adenosine in the Nervous System

  1991cited by this paper
• Fluorescent and biotin probes for dopamine receptors: D1 and D2 receptor affinity and selectivity.

  1990cited by this paper
• Characterization of benzodiazepine receptors with a fluorescence-quenching ligand.

  1990cited by this paper
• Characterization of benzodiazepine receptors with fluorescent ligands

  1990cited by this paper
• Adenosine Receptor Sub-types in Isolated Tissues: Antagonist Studies

  1990cited by this paper
• Drug and neurotransmitter receptors. New perspectives with clinical relevance.

  1989cited by this paper
• Characterization of Novel Fluorescent Ligands with High Affinity for D1 and D2 Dopaminergic Receptors

  1989cited by this paper
• Direct visualization and cellular localization of D1 and D2 dopamine receptors in rat forebrain by use of fluorescent ligands.

  1989cited by this paper
• Agonist derived molecular probes for A2 adenosine receptors

  1989cited by this paper
• Distribution and lateral mobility of GABA/benzodiazepine receptors on nerve cells

  1989cited by this paper
• [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

  1989cited by this paper
• Species differences in high‐affinity adenosine A2 binding sites in striatal membranes from mammalian brain

  1988cited by this paper
• Molecular probes for extracellular adenosine receptors.

  1987cited by this paper
• Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.

  1986cited by this paper
• Neurotransmitter Receptor Binding

  1984cited by this paper

• Ligand Binding Kinetics to Evaluate Function and Stability of A2AR in Nanodiscs.

  2024cites this paper
• Biophysical Dissection of Isolated GPCRs: The Adenosine A2A Receptor under the Bistouries

  2023cites this paper
• Fluorescent A2A and A3 adenosine receptor antagonists as flow cytometry probes

  2022cites this paper
• Characterization of binding kinetics of A2AR to Gαs protein by surface plasmon resonance.

  2021cites this paper
• Bridging non-overlapping reads illuminates high-order epistasis between distal protein sites in a GPCR

  2020cites this paper
• Molecular probes for the human adenosine receptors

  2020cites this paper
• Chemical Probes for the Adenosine Receptors

  2019cites this paper
• Fluorescent-Labeled Selective Adenosine A2B Receptor Antagonist Enables Competition Binding Assay by Flow Cytometry.

  2018cites this paper
• A2AR Binding Kinetics in the Ligand Depletion Regime

  2017cites this paper
• Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands.

  2015cites this paper
• Conserved disulfide bond is not essential for the adenosine A2A receptor: Extracellular cysteines influence receptor distribution within the cell and ligand-binding recognition.

  2015influential citation
• Synthesis of BODIPY Derivatives Substituted with Various Bioconjugatable Linker Groups: A Construction Kit for Fluorescent Labeling of Receptor Ligands

  2013cites this paper
• Fluorescent ligands for adenosine receptors.

  2013cites this paper
• Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry.

  2012cites this paper
• Novel Alexa Fluor-488 labeled antagonist of the A(2A) adenosine receptor: Application to a fluorescence polarization-based receptor binding assay.

  2010cites this paper
• Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).

  2009cites this paper
• Brand „ Agonist-induced Signaling and Endocytosis of the Adenosine A 2 A Receptor “

  2007cites this paper
• Agonists and antagonists for P2 receptors.

  2006cites this paper
• Adenosine A1 and A3 receptors: Distinct cardioprotection

  2001cites this paper
• Adenosine and ischemic preconditioning.

  1999cites this paper
• Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.

  1997cites this paper
• Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.

  1996cites this paper
• Molecular probes for muscarinic receptors: functionalized congeners of selective muscarinic antagonists.

  1995cites this paper
• Solubilized rabbit striatal A2a-adenosine receptors: stability and antagonist binding.

  1993cites this paper
• 8‐(3‐Isothiocyanatostyryl)caffeine is a selective, irreversible inhibitor of striatal A2‐Adenosine receptors

  1993cites this paper